Our previous study established a five‐CpG‐based classifier for ccRCC prognosis, which identified EHBP1L1 as a prognosis‐related gene in RCC.[25] In the present study, we identified EHBP1L1 as a crucial contributor to tumor immune evasion in RCC. This evidence concerns the gene EHBP1L1 and renal cell carcinoma.